Navigation Links
ETH Zurich professor Ari Helenius awarded Benoist Prize
Date:9/24/2007

Why do we catch colds? How do viruses get into cells? In pursuing this central question, Ari Helenius, Professor of Biochemistry at ETH Zurich since 1997, and his team have pioneered research in this field. For his efforts, Professor Helenius has today been awarded the Swiss Nobel Prize in Bern, Switzerland. This award is not only for me but for the entire team as well a confirmation of our long years of work, and demonstration of the good working conditions that exist for researchers at ETH Zurich, Professor Helenius said.

Discoverer of Endosomes

Viruses are parasites that need to feed from living cells in order to replicate. The membrane covering each cell creates an effective barrier against infiltration by undesired substances. The supposition to date had been that viruses invade cells through fusion with the plasma membrane, in the same way that two soap bubbles collide with one another, then fuse. Helenius found instead that the vi-ruses are carried by a cellular mechanism to an internal location in the cyto-plasma where the lower pH value promotes penetration into the cytosol and eventually the nucleus. Working from this finding, Helenius discovered the so-called endosome, a structured, intracellular membrane bubble that provides the acidic environment that allows the fusion of virus and cell.

Increased insight into cellular quality control

Virologists are not the only ones to benefit from Heleniuss reseach. Cell biolo-gists have also profited. Heleniuss work with viruses has led to the identification of underlying mechanisms of cell biology. One of these mechanisms is a quality control system that newly synthesized proteins, such as hormones and en-zymes, have to pass before they are deployed by the cell to perform their func-tion. While studying the synthesis of viral proteins in the infected cell, Helenius and co-workers observed that defective, incorrectly folded viral proteins failed to be transported to
'/>"/>

Contact: Ari Helenius
ari.helenius@bc.biol.ethz.ch
41-446-326-817
Swiss Federal Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Great White shark evolution debate involves WSU Lake Campus geology professor
2. K-State professors discover enzyme responsible for creation of a beetles hard shell
3. Pitt professors theory of evolution gets boost from cell research
4. DNA conclusive yet still controversial, Carnegie Mellon professor says
5. Professors to develop hand-held pathogen testing device
6. LSU professor discovers new species
7. TGen awarded $7.1 million to accelerate brain disease research
8. LEGO-Like building blocks to halt cell growth wins Hebrew University prize
9. Comments, experts and background on the 2006 Nobel Prize in chemistry
10. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
11. Australian wins prestigious prize in biodiversity informatics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Toxic dust: Toxins in coal-tar-based sealcoats in ...use dust, according to a USGS study. PAHs or pol... found in oil, coal and tar deposits, and can have... often found in house dust; however, the specific ...searchers found that dust from indoor areas near p...
(Date:11/20/2009)... obstructive pulmonary disease (COPD), a respirato... emphysema, is the fourth leading cause of death w...hile researchers have yet to find any real treatme...itute at The University of Western Ontario in Lond... gain new insight into the disease. , Parrag...
(Date:11/19/2009)... Leaf-cutter ants, which cultivate fungus for foo...ew one to add to the list: the ant farmers, like t... bacteria to make their gardens grow. The finding,...nce , documents a previously unknown symbiosis bet...ow leaf-cutter ants have come to dominate the Amer...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Like humans, ants use bacteria to make their gardens grow 24th Annual Henry Schein Think Pink Practice Pink Campaign Coincides With Breast Cancer Awareness Month 60383 14th Annual Henry Schein Think Pink Practice Pink Campaign Coincides With Breast Cancer Awareness Month 60383 24th Annual Henry Schein Think Pink Practice Pink Campaign Coincides With Breast Cancer Awareness Month 60383 3Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter 5865 1Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter 5865 2Children 26apos 3Bs Hospital Physician Honored for Research 60381 1Children 26apos 3Bs Hospital Physician Honored for Research 60381 2Children 26apos 3Bs Hospital Physician Honored for Research 60381 3
...vaccine against HIV infection have been given a mu...obal HIV/AIDS Vaccine Enterprise,s,scientific stra...le,open-access global health journal PLoS Medicin...ternational alliance of,independent agencies and o...research. In June 2004, the G8 countries endorsed ...
...won a £261,000 grant to use the latest software to... stop influenza and some other diseases from repli... comes at a time when fears are rising that an inf...ld kill thousands of people. , Professor Ian Will...ork in April on a project that could help pharmace...
...t microarray-based experiments,reproductibility, ...st,these results? If I redo the same experiment in...H recently demonstrated that microarrays experime...gree of reproducibility , as long as standardized ...the scientific community (and the microarrays prod...
Other Biology News:A much-needed shot in the arm for HIV vaccine development 2A much-needed shot in the arm for HIV vaccine development 3Computers to be used to find blueprint for new influenza drug 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 3
(Date:11/19/2009)...ople would like to be able to charge their cell ph...t too often. A recent discovery made by UC San Die...upercapacitors that could do just this. , In re...rs , Prabhakar Bandaru, a professor in the UCSD De...along with graduate student Mark Hoefer, have foun...
(Date:11/19/2009)...BLAUVELT, N.Y., Nov. 19 Dr. Mate H...tract, responds to a press release issued on Novem...an company for making false and self-serving state...es. ,, Dr. Hidvegi stated from his office in B...t research on Avemar does not apply to AveULTRA, ...
(Date:11/19/2009)...BETHESDA, Md., Nov. 19 S... in biotechnology for diabetes therapy, and a prov...es to food, supplement, biotechnology and pharmace...uesday,s Annual Meeting of Shareholders. ,, At ...(Nasdaq: SPEX ) elected the following members to ...
(Date:11/19/2009)...MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeuti...tient in a randomized Phase 2B study of AEG35156, ...lopment for multiple oncology indications. ,, T... 2 Study of the X-Linked Inhibitor of Apoptosis (X...High-dose Cytarabine and Idarubicin in AML Followi...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...ous Guidance for 2007, MADISON, N.J., Jan. 17 Qu...tion,s leading provider of diagnostic,testing, inf...rt results,for the fourth quarter and year ended D...r 2008 on February 21, 2008, instead of the previo...s rescheduling its report of fourth quarter and fu...
...., Jan. 17 Peptimmune, Inc., a privately,held bio...d a first close,of $8.2 million of a Series D pref...ed by New Enterprise Associates, MPM Capital, Hunt...on Valley Bank Capital, as well as,certain other i... Company,expects a second close in Q2/2008, which ...
... Support a Marketing Authorization Application in ...OUSTON, Jan. 17 Agennix Incorporated announced to...A) has approved the design of,a single, pivotal, P...errin alfa, in combination with chemotherapy as fi... lung cancer (NSCLC) under the,Special Protocol As...
Other Biology Technology:Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results 2Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results 3Peptimmune Announces First Close of Series D Private Financing 2Peptimmune Announces First Close of Series D Private Financing 3Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 2Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 3Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 4Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 5
...plications for the use of small interfering RNA (s... RNA interference (RNAi) pathway have generated tr...ology fields. siRNA for experimental use can be sy...ally, and then transfected into the target cells i...
...ogical data hidden in your samples with eArray and...acturing allows you to create your own microarray ...Design at your own pace and receive delivery of yo...is a secure, online array creation application too...
...les are used to study co-translational and initial...sing events such as signal peptide cleavage, membr...n can be examined by the translation of the approp...somal membranes. In addition, processing and glyco...
Mouse Anti-Human Procollagen type I C-terminal propeptide (PICP) Monoclonal Antibody, Unconjugated from AntibodyShop A/S
Biology Products: